These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

401 related articles for article (PubMed ID: 29735575)

  • 1. Acute and Persistent Hepatitis E Virus Genotype 3 and 4 Infection: Clinical Features, Pathogenesis, and Treatment.
    Kamar N; Pischke S
    Cold Spring Harb Perspect Med; 2019 Jul; 9(7):. PubMed ID: 29735575
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute Hepatitis E: Two Sides of the Same Coin.
    Hartl J; Wehmeyer MH; Pischke S
    Viruses; 2016 Nov; 8(11):. PubMed ID: 27827877
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Clinical Perspective on Hepatitis E.
    Horvatits T; Schulze Zur Wiesch J; Lütgehetmann M; Lohse AW; Pischke S
    Viruses; 2019 Jul; 11(7):. PubMed ID: 31284447
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis E virus: Epidemiology, diagnosis, clinical manifestations, and treatment.
    Aslan AT; Balaban HY
    World J Gastroenterol; 2020 Oct; 26(37):5543-5560. PubMed ID: 33071523
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of active hepatitis E virus infection and efficacy of ribavirin treatment in renal allograft recipients.
    Friebus-Kardash J; Eisenberger U; Ackermann J; Kribben A; Witzke O; Wenzel J; Rohn H; Fiedler M
    Transpl Infect Dis; 2019 Jun; 21(3):e13088. PubMed ID: 30929308
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of autochthonous acute hepatitis E with short-term ribavirin: a multicenter retrospective study.
    Péron JM; Abravanel F; Guillaume M; Gérolami R; Nana J; Anty R; Pariente A; Renou C; Bureau C; Robic MA; Alric L; Vinel JP; Izopet J; Kamar N
    Liver Int; 2016 Mar; 36(3):328-33. PubMed ID: 26179015
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of hepatitis E virus.
    Dalton HR; Kamar N
    Curr Opin Infect Dis; 2016 Dec; 29(6):639-644. PubMed ID: 27607911
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Review article: hepatitis E-a concise review of virology, epidemiology, clinical presentation and therapy.
    Donnelly MC; Scobie L; Crossan CL; Dalton H; Hayes PC; Simpson KJ
    Aliment Pharmacol Ther; 2017 Jul; 46(2):126-141. PubMed ID: 28449246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ribavirin Treatment Failure-Associated Mutation, Y1320H, in the RNA-Dependent RNA Polymerase of Genotype 3 Hepatitis E Virus (HEV) Enhances Virus Replication in a Rabbit HEV Infection Model.
    Wang B; Mahsoub HM; Li W; Heffron CL; Tian D; Hassebroek AM; LeRoith T; Meng XJ
    mBio; 2023 Apr; 14(2):e0337222. PubMed ID: 36809085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The burden of hepatitis E among patients with haematological malignancies: A retrospective European cohort study.
    von Felden J; Alric L; Pischke S; Aitken C; Schlabe S; Spengler U; Giordani MT; Schnitzler P; Bettinger D; Thimme R; Xhaard A; Binder M; Ayuk F; Lohse AW; Cornelissen JJ; de Man RA; Mallet V
    J Hepatol; 2019 Sep; 71(3):465-472. PubMed ID: 31108159
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical features and determinants of chronicity in hepatitis E virus infection.
    Narayanan S; Abutaleb A; Sherman KE; Kottilil S
    J Viral Hepat; 2019 Apr; 26(4):414-421. PubMed ID: 30636092
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic hepatitis E in a heart transplant patient: sofosbuvir and ribavirin regimen not fully effective.
    Todesco E; Mazzola A; Akhavan S; Abravanel F; Poynard T; Roque-Afonso AM; Peytavin G; Marcelin AG; Calmus Y; Lecuyer L; Guillemain R; Conti F
    Antivir Ther; 2018; 23(5):463-465. PubMed ID: 29504509
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dosing ribavirin in hepatitis E-infected solid organ transplant recipients.
    De Winter BCM; Hesselink DA; Kamar N
    Pharmacol Res; 2018 Apr; 130():308-315. PubMed ID: 29499270
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Course and treatment of chronic hepatitis E virus infection in lung transplant recipients.
    Pischke S; Greer M; Hardtke S; Bremer B; Gisa A; Lehmann P; Haverich A; Welte T; Manns MP; Wedemeyer H; Gottlieb J;
    Transpl Infect Dis; 2014 Apr; 16(2):333-9. PubMed ID: 24438577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Infection with hepatitis E virus in kidney transplant recipients in southeastern France.
    Moal V; Legris T; Burtey S; Morange S; Purgus R; Dussol B; Garcia S; Motte A; Gérolami R; Berland Y; Colson P
    J Med Virol; 2013 Mar; 85(3):462-71. PubMed ID: 23239466
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Chronic Hepatitis E Virus Infection and Treatment in Organ Transplant Recipients].
    Chen S; Wei F; Wu T; Xia N
    Bing Du Xue Bao; 2015 May; 31(3):293-8. PubMed ID: 26470537
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of hepatitis E in the liver transplant setting.
    Behrendt P; Steinmann E; Manns MP; Wedemeyer H
    J Hepatol; 2014 Dec; 61(6):1418-29. PubMed ID: 25195557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [An update on hepatitis E].
    Hiroz P; Gouttenoire J; Dao Thi VL; Sahli R; Telenti A; Moradpour D; Doerig C
    Rev Med Suisse; 2013 Sep; 9(396):1594, 1596-8. PubMed ID: 24066468
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence, morbidity, and therapy of hepatitis E virus infection in pediatric renal allograft recipients.
    Cordts SE; Schneble L; Schnitzler P; Wenzel JJ; Vinke T; Rieger S; Fichtner A; Tönshoff B; Höcker B
    Pediatr Nephrol; 2018 Jul; 33(7):1215-1225. PubMed ID: 29500631
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is hepatitis E virus an emerging problem in industrialized countries?
    Sayed IM; Vercouter AS; Abdelwahab SF; Vercauteren K; Meuleman P
    Hepatology; 2015 Dec; 62(6):1883-92. PubMed ID: 26175182
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.